2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
| Defining care pathways for infants with risk factors for late-onset/progressive hearing loss.
Defining care pathways for infants with risk factors for late-onset/progressive hearing loss.
Newborn hearing screening (NBHS) identifies infants with congenital hearing loss, while additional pathways are needed to target identification of infants who develop hearing loss after the immediate birth period. Established risk factors for late-onset/progressive hearing loss determine which children warrant continued hearing monitoring beyond NBHS. The 2019 JCIH position statement identifies 12 (perinatal and postnatal) risk factor classifications and recommends that infants with most risk factors for late-onset/progressive hearing loss have at least one diagnostic hearing evaluation by nine months of age. The specifics of which audiologic tests are used to meet this aim may vary and is one of the priorities of this project. Specifically, obtaining a comprehensive hearing evaluation for infants can be a challenge, especially for neonatal intensive care unit (NICU)-graduates, who often have a history of premature birth or developmental delay.
In this project, we review our practice’s adaptation of the JCIH 2019 risk factor identification and follow-up pathways for those identified as at increased risk of late-onset/progressive hearing loss. During the first two months of 2021, 35 out of 42 babies (83%) screened at Mayo Clinic level 4 NICU and 38 out of 48 babies (79%) screened at the level 3 NICU were identified as having at least one risk factor for late-onset/progressive hearing loss. This project seeks to define and optimize hearing monitoring pathways for infants with risk factors for late-onset/progressive hearing loss through discussion of our efforts to maximize protocols in the NICU and outpatient settings. Review of NBHS outcomes and clinical data from infants at increased risk of late-onset/progressive hearing loss will be presented.
- Describe updates in the JCIH 2019 recommendation as they pertain to newborns with risk factors for hearing loss.
- Recognize the importance of defining care pathways to audiologic assessment by 9 months of age for those with risk factors associated with late onset/progressive hearing loss.
- Describe the challenges and potential solutions associated with the implementation of audiologic assessment by 9 months of age for those with risk factors associated with late onset/progressive hearing loss.
Presentation:
3353554_14943KaitlynCaceres.pdf
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Kaitlyn Caceres
(Primary Presenter,Co-Presenter,Author,Co-Author), Mayo Clinic, caceres.kaitlyn@mayo.edu;
Kaitlyn Caceres, Au.D. works as a pediatric audiologist at the Mayo Clinic in Rochester, Minnesota. She obtained her Au.D. at the University of Wisconsin-Madison. She has a passion for working with children with complex health needs and their families.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Joscelyn Martin
(Co-Presenter,Author,Co-Author), Mayo Clinic Rochester, martin.joscelyn@mayo.edu;
Joscelyn R.K. Martin, Au.D. is a pediatric audiologist at the Mayo Clinic in Rochester, Minnesota. She holds Pediatric Audiology Specialty Certification (PASC) from the American Board of Audiology. Dr. Martin has been coordinator of the Mayo Clinic Early Hearing Detection and Intervention (EHDI) program since its inception in 1999. In addition to early intervention for children with hearing loss, she is passionate about child and family centered counseling and the positive impact it has on the diagnostic and re/habilitative process for the families with whom she works.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Shelagh Cofer
(Author,Co-Author), Mayo Clinic, Cofer.Shelagh@mayo.edu;
Shelagh Cofer, M.D. is a pediatric otolaryngologist with specialty interest in complex pediatric otolaryngology conditions and/or medically complex patients with common otorhinolaryngology problems. She completed medical school at University of Illinois College of Medicine at Chicago, residency at the University of Illinois Medical Center Chicago, and fellowship training at Minneapolis Children’s Hospital, University of Minnesota. Dr. Cofer directs Mayo's Pediatric Otolaryngology Division, the Aerodigestive Clinic and the Velopharyngeal Insufficiency Clinic. Dr. Cofer investigates diseases in children affecting all aspects of the ears, nose and throat. Her approach to research is one of collaboration with colleagues, other specialists and primary care providers to drive new approaches to care for children with complex or common problems.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Jane Brumbaugh
(Author,Co-Author), Mayo Clinic, Brumbaugh.Jane@mayo.edu;
Dr. Brumbaugh is a neonatologist and clinical investigator with research interests focused on cognition, behavior, and neuroimaging of the preterm population. She completed her medical school, residency, and fellowship training at the University of Minnesota. She has utilized neuropsychological assessment, event-related potentials, and magnetic resonance imaging in structural and functional assessment of the developing brain. She served as the Follow-up Principal Investigator for the University of Iowa in the NICHD Neonatal Research Network from 2013-2017 and the Medical Director for the High Risk Infant Follow-up Program at the University of Iowa Children’s Hospital from 2015-2017. In 2017, Dr. Brumbaugh joined the faculty at the Mayo Clinic where she cares for patients in the neonatal intensive care unit. Currently, she is studying outcomes of infants affected by retinopathy of prematurity and by late-onset meningitis.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Gayla L. Poling
(Co-Presenter,Author,Co-Author), Mayo Clinic, Rochester, MN, poling.gayla@mayo.edu;
Gayla L. Poling, Ph.D. is the Director of Diagnostic Audiology Research at Mayo Clinic, Rochester, MN. She is an Assistant Professor of Audiology, Mayo Clinic College of Medicine. She studied Audiology and Hearing Sciences at The Ohio State University and completed postdoctoral fellowships at the Medical University of South Carolina and Northwestern University. Her primary interest is auditory diagnostics with her research focused on early detection and prevention of hearing loss across the life course.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -